rss
Frontline Gastroenterol 2:199-205 doi:10.1136/flgastro-2011-100006
  • Clinical quality

What you need to know when you prescribe a proton pump inhibitor

  1. C J Hawkey
  1. Nottingham Digestive Diseases Centre, University Hospitals Trust, Nottingham, UK
  1. Correspondence to C J Hawkey, Nottingham Digestive Diseases Centre, E Floor West Block, University Hospitals Nottingham, Nottingham NG7 2UH, UK; cj.hawkey{at}nottingham.ac.uk
  • Accepted 16 April 2011
  • Published Online First 24 June 2011

Abstract

Ever since they were launched, proton pump inhibitors (PPIs) have been regarded as profligate prescription interventions and have become a favourite target for pharmacy advisers. Now that they are cheap, with generic omeprazole 20 mg daily costing £1.88 per month (£24.51 per annum) in the UK, it is time to ask whether this status should be reviewed, whether there are areas where the message should be reversed and whether there are any circumstances in which the extra cost of branded PPIs or combined preparations is justified. Equally, with the recognition of an extended toxicity profile, is prescribing profligacy not an economic but a safety issue?

Footnotes

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of FG.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article